Myomo, Inc. Stock Added to Russell Microcap® Index
BOSTON, Mass. (June 28, 2021) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that its stock will be added to the Russell Microcap® Index at the opening of trading today. Read more.
Myomo to Present at Sidoti Virtual Investor Conference on June 23, 2021
BOSTON, Mass. (June 16, 2021) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that Paul R. Gudonis, Chief Executive Officer, and David Henry, Chief Financial Officer, will present a corporate overview of the […]
Myomo Shareholders Elect Dr. Milton Morris as Director
Inventor, Researcher, Medical Device Manufacturer Executive BOSTON, Mass. (June 14, 2021) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that its shareholders, at its meeting on June 9, 2021, elected Milton Morris, PhD, […]
Myomo Provides Update on CMS Discussions
BOSTON, Mass. (June 8, 2021) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today provided an update regarding its application for a Healthcare Common Procedure Coding System (“HCPCS”) Level II code change and benefit category […]
Myomo to Present at the Summer Solstice – Best Ideas From the Buy Side Conference
BOSTON, Mass. (May 27, 2021) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that CEO Paul R. Gudonis and CFO David Henry will present at the Summer Solstice – Best Ideas From the […]
Myomo Reports First Quarter 2021 Financial Results
Revenue of $2.3 million up 132% over prior year Gross margin of 73% up 500 basis points over prior year Q1 cash used in operations decreased 14% to $2.1 million Conference call begins at 4:30 p.m. Eastern time today BOSTON, Mass. (May 5, 2021) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a […]
Myomo to Report First Quarter 2021 Financial Results on May 5, 2021
BOSTON, Mass., (April 27, 2021) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for the three months ended March 31, 2021 on May 5, 2021 after the […]
Myomo Participates in Ground-breaking Brain-computer Interface Trial
Thomas Jefferson University Successfully Controls MyoPro Directly from Brain Implant BOSTON, Mass. (April 1, 2021) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that Thomas Jefferson University of Philadelphia has successfully completed the […]
Myomo Reports Fourth Quarter and Full Year 2020 Financial Results
Record Q4 2020 revenue of $3.8 million up 149% over prior year Full year 2020 revenue of $7.6 million up 98% vs. 2019 Q4 gross margin of 73% up 100 basis points over prior year Q4 cash used in operations of $1.2 million lowest since June 2017 IPO Conference call begins at 4:30 p.m. Eastern […]
Myomo to Participate in Three Investment Conferences During the Month of March
BOSTON, Mass., March 4, 2021– Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that Paul R. Gudonis, Myomo’s CEO, and David Henry, Myomo’s CFO will participate in three virtual investment conferences during the month […]